Sequenom Will Roll Out New Product Every Other Quarter; Will Firm Split in Two? | GenomeWeb

This updated version serves to clarify a misstatement of fact made by a Sequenom official related to the company's cash position. Sequenom currently has $105 million in the bank and will burn roughly $35 million over the next 12 months.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.